Growth Control: How Vascular Growth Inhibitors Are Shaping Modern Oncology
The Angiogenesis Therapeutic Agent Market is experiencing transformative growth as vascular growth inhibitors continue to shape modern oncology and cancer care. According to market reports, the global Angiogenesis Therapeutic Agent Market was valued at USD 25.4 billion in 2024 and is projected to reach USD 37.8 billion by 2035, exhibiting a CAGR of 3.7% during the forecast period....
0 Yorumlar 0 hisse senetleri 158 Views 0 önizleme